vs
Biglari Holdings Inc.（BH）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Biglari Holdings Inc.的2.0倍（$197.9M vs $99.9M），REPLIGEN CORP净利率更高（6.7% vs -49.9%，领先56.6%），REPLIGEN CORP同比增速更快（13.6% vs 9.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $6.4M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 5.7%）
Biglari控股是一家总部位于美国得克萨斯州圣安东尼奥的控股公司，由企业家萨达尔·比格拉里创立。旗下业务涵盖餐饮、出版、保险、石油能源多个领域，旗下子品牌包括Steak 'n Shake、《马克西姆》杂志、第一卫士保险、南先锋保险、南方石油、阿布拉克萨斯石油等。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
BH vs RGEN — 直观对比
营收规模更大
RGEN
是对方的2.0倍
$99.9M
营收增速更快
RGEN
高出4.0%
9.6%
净利率更高
RGEN
高出56.6%
-49.9%
自由现金流更多
RGEN
多$11.2M
$6.4M
两年增速更快
RGEN
近两年复合增速
5.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $99.9M | $197.9M |
| 净利润 | $-49.9M | $13.3M |
| 毛利率 | 58.3% | 52.5% |
| 营业利润率 | -64.1% | 9.0% |
| 净利率 | -49.9% | 6.7% |
| 营收同比 | 9.6% | 13.6% |
| 净利润同比 | -385.3% | 143.9% |
| 每股收益（稀释后） | — | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BHRGEN
| Q4 25 | $99.9M | $197.9M | ||
| Q3 25 | $99.7M | $188.8M | ||
| Q2 25 | $100.6M | $182.4M | ||
| Q1 25 | $95.0M | $169.2M | ||
| Q4 24 | $91.1M | $174.1M | ||
| Q3 24 | $90.4M | $154.9M | ||
| Q2 24 | $91.1M | $154.1M | ||
| Q1 24 | $89.5M | $151.3M |
净利润BHRGEN
| Q4 25 | $-49.9M | $13.3M | ||
| Q3 25 | $-5.3M | $14.9M | ||
| Q2 25 | $50.9M | $14.9M | ||
| Q1 25 | $-33.3M | $5.8M | ||
| Q4 24 | $-10.3M | $-30.3M | ||
| Q3 24 | $32.1M | $-654.0K | ||
| Q2 24 | $-48.2M | $3.3M | ||
| Q1 24 | $22.6M | $2.1M |
毛利率BHRGEN
| Q4 25 | 58.3% | 52.5% | ||
| Q3 25 | 58.1% | 53.2% | ||
| Q2 25 | 60.2% | 50.0% | ||
| Q1 25 | 60.3% | 53.6% | ||
| Q4 24 | 60.6% | 26.1% | ||
| Q3 24 | 59.9% | 50.0% | ||
| Q2 24 | 59.5% | 49.8% | ||
| Q1 24 | 61.5% | 49.5% |
营业利润率BHRGEN
| Q4 25 | -64.1% | 9.0% | ||
| Q3 25 | -7.6% | 8.9% | ||
| Q2 25 | 64.7% | 7.6% | ||
| Q1 25 | -43.3% | 3.9% | ||
| Q4 24 | -19.7% | -17.7% | ||
| Q3 24 | 47.9% | -5.1% | ||
| Q2 24 | -69.0% | 1.0% | ||
| Q1 24 | 32.9% | 1.3% |
净利率BHRGEN
| Q4 25 | -49.9% | 6.7% | ||
| Q3 25 | -5.3% | 7.9% | ||
| Q2 25 | 50.6% | 8.2% | ||
| Q1 25 | -35.0% | 3.4% | ||
| Q4 24 | -11.3% | -17.4% | ||
| Q3 24 | 35.5% | -0.4% | ||
| Q2 24 | -52.9% | 2.2% | ||
| Q1 24 | 25.2% | 1.4% |
每股收益（稀释后）BHRGEN
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | $0.26 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.10 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | — | $-0.01 | ||
| Q2 24 | — | $0.06 | ||
| Q1 24 | — | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $268.8M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $523.4M | $2.1B |
| 总资产 | $1.0B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资BHRGEN
| Q4 25 | $268.8M | $767.6M | ||
| Q3 25 | $272.5M | $748.7M | ||
| Q2 25 | $32.8M | $708.9M | ||
| Q1 25 | $28.7M | $697.2M | ||
| Q4 24 | $30.7M | $757.4M | ||
| Q3 24 | $29.9M | $784.0M | ||
| Q2 24 | $26.9M | $809.1M | ||
| Q1 24 | $34.5M | $780.6M |
总债务BHRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益BHRGEN
| Q4 25 | $523.4M | $2.1B | ||
| Q3 25 | $580.3M | $2.1B | ||
| Q2 25 | $589.3M | $2.1B | ||
| Q1 25 | $539.8M | $2.0B | ||
| Q4 24 | $573.0M | $2.0B | ||
| Q3 24 | $601.8M | $2.0B | ||
| Q2 24 | $569.2M | $2.0B | ||
| Q1 24 | $618.6M | $2.0B |
总资产BHRGEN
| Q4 25 | $1.0B | $2.9B | ||
| Q3 25 | $1.1B | $2.9B | ||
| Q2 25 | $863.6M | $2.9B | ||
| Q1 25 | $829.1M | $2.9B | ||
| Q4 24 | $866.1M | $2.8B | ||
| Q3 24 | $865.1M | $2.8B | ||
| Q2 24 | $809.1M | $2.9B | ||
| Q1 24 | $885.3M | $2.8B |
负债/权益比BHRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.8M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $6.4M | $17.6M |
| 自由现金流率自由现金流/营收 | 6.4% | 8.9% |
| 资本支出强度资本支出/营收 | 11.4% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $76.6M | $93.9M |
8季度趋势，按日历期对齐
经营现金流BHRGEN
| Q4 25 | $17.8M | $25.7M | ||
| Q3 25 | $31.2M | $48.1M | ||
| Q2 25 | $42.1M | $28.6M | ||
| Q1 25 | $15.8M | $15.0M | ||
| Q4 24 | $18.0M | $39.2M | ||
| Q3 24 | $10.8M | $49.3M | ||
| Q2 24 | $1.8M | $42.2M | ||
| Q1 24 | $19.1M | $44.7M |
自由现金流BHRGEN
| Q4 25 | $6.4M | $17.6M | ||
| Q3 25 | $22.3M | $43.4M | ||
| Q2 25 | $39.4M | $21.5M | ||
| Q1 25 | $8.5M | $11.4M | ||
| Q4 24 | $10.9M | $33.6M | ||
| Q3 24 | $3.7M | $42.3M | ||
| Q2 24 | $-10.0M | $37.4M | ||
| Q1 24 | $14.5M | $36.4M |
自由现金流率BHRGEN
| Q4 25 | 6.4% | 8.9% | ||
| Q3 25 | 22.4% | 23.0% | ||
| Q2 25 | 39.2% | 11.8% | ||
| Q1 25 | 8.9% | 6.8% | ||
| Q4 24 | 12.0% | 19.3% | ||
| Q3 24 | 4.1% | 27.3% | ||
| Q2 24 | -11.0% | 24.3% | ||
| Q1 24 | 16.2% | 24.0% |
资本支出强度BHRGEN
| Q4 25 | 11.4% | 4.1% | ||
| Q3 25 | 9.0% | 2.5% | ||
| Q2 25 | 2.7% | 3.9% | ||
| Q1 25 | 7.7% | 2.1% | ||
| Q4 24 | 7.8% | 3.2% | ||
| Q3 24 | 7.8% | 4.5% | ||
| Q2 24 | 13.0% | 3.1% | ||
| Q1 24 | 5.1% | 5.5% |
现金转化率BHRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | 0.83× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | 0.85× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BH
| Products | $45.9M | 46% |
| Franchisor | $20.5M | 21% |
| Insurance Operations | $19.1M | 19% |
| Oil And Gas Segment | $5.4M | 5% |
| Royalty | $4.1M | 4% |
| Abraxas Petroleum | $2.7M | 3% |
| Other | $2.2M | 2% |
RGEN
暂无分部数据
